» Articles » PMID: 2504342

Excess Benign Melanocytic Naevi After Chemotherapy for Malignancy in Childhood

Overview
Journal BMJ
Specialty General Medicine
Date 1989 Jul 8
PMID 2504342
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To see whether children who have had chemotherapy develop increased numbers of moles.

Design: Blind assessment of patients having chemotherapy and subsequent comparison with the first suitable patients matched for age and sex who were attending the clinic during the same period after having completed treatment. Controls were obtained the following year by taking the first suitable patients attending a routine dermatology outpatient clinic who matched the study groups for age and sex.

Setting: Referrals to a paediatric oncology clinic and a dermatology clinic at two city hospitals.

Patients: The group receiving chemotherapy comprised all 32 patients with acute lymphatic leukaemia, lymphoma, and rhabdomyosarcoma who were attending the paediatric oncology clinic on two mornings a week during October 1987 to March 1988. The group who had completed treatment comprised 32 patients who were attending for follow up during the same period and who matched the first group for age and sex. Thirty two other patients attending the dermatology outpatient clinic with unrelated skin conditions served as controls.

End Point: Definite increase in numbers of moles on children after a course of chemotherapy.

Measurements And Main Results: Moles were counted by one observer on defined areas of the body and divided into those less than 3 mm and greater than or equal to 3 mm diameter. Patients receiving chemotherapy had a similar number of moles to the control group. By contrast patients who had completed chemotherapy had significant increases both in moles less than 3 mm and greater than or equal to 3 mm and in the total number of moles. These patients were more likely to have moles on acral sites.

Conclusions: Children with substantially increased numbers of moles (benign melanocytic naevi) after successful chemotherapy for malignancy may have an increased risk of melanoma. They should be offered prolonged surveillance and cautioned about exposure to ultraviolet light.

Citing Articles

Risk of melanocytic nevi and nonmelanoma skin cancer in children after allogeneic hematopoietic stem cell transplantation.

Song J, London W, Hawryluk E, Guo D, Sridharan M, Fisher D Bone Marrow Transplant. 2017; 52(7):989-997.

PMID: 28368380 DOI: 10.1038/bmt.2017.57.


Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study.

Bilmon I, Ashton L, Le Marsney R, Dodds A, OBrien T, Wilcox L Bone Marrow Transplant. 2014; 49(5):691-8.

PMID: 24535126 DOI: 10.1038/bmt.2014.13.


Melanocytic naevi and melanoma in survivors of childhood cancer.

Green A, Smith P, Mcwhirter W, ORegan P, Battistutta D, Yarker M Br J Cancer. 1993; 67(5):1053-7.

PMID: 8494698 PMC: 1968436. DOI: 10.1038/bjc.1993.193.


Melanoma risk factors and atypical moles.

Williams M, Sagebiel R West J Med. 1994; 160(4):343-50.

PMID: 8023484 PMC: 1022426.


Late effects of total body irradiation.

Leiper A Arch Dis Child. 1995; 72(5):382-5.

PMID: 7618901 PMC: 1511084. DOI: 10.1136/adc.72.5.382.


References
1.
Green A, MACLENNAN R, Siskind V . Common acquired naevi and the risk of malignant melanoma. Int J Cancer. 1985; 35(3):297-300. DOI: 10.1002/ijc.2910350303. View

2.
Tucker M, Misfeldt D, Coleman C, Clark Jr W, Rosenberg S . Cutaneous malignant melanoma after Hodgkin's disease. Ann Intern Med. 1985; 102(1):37-41. DOI: 10.7326/0003-4819-102-1-37. View

3.
Mackie R, English J, Aitchison T, Fitzsimons C, Wilson P . The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population. Br J Dermatol. 1985; 113(2):167-74. DOI: 10.1111/j.1365-2133.1985.tb02060.x. View

4.
Greene M, Wilson J . Second cancer following lymphatic and hematopoietic cancers in Connecticut, 1935-82. Natl Cancer Inst Monogr. 1985; 68:191-217. View

5.
Ellis D, Wheeland R . Increased nevus estrogen and progesterone ligand binding related to oral contraceptives or pregnancy. J Am Acad Dermatol. 1986; 14(1):25-31. DOI: 10.1016/s0190-9622(86)70002-9. View